Compared to Control what was the result of Allogeneic mesenchymal precursor cells on Knee Injury and Osteoarthritis Outcome Score improvement ?
However, significant differences between treatment groups were observed for KOOS symptoms and pain at 18 months (both p = 0.03) and 24 months (p = 0.04 and 0.02, respectively), and for ADL at 18 months (p = 0.04), all in favour of patients who were injected with the MPC + HA preparation